Prothrombin 20210A Mutation

Authors:
  • ELEduard J. Libourel
    Eduard J. Libourel
  • SMSaskia Middeldorp
    Saskia Middeldorp
  • EPElisabeth C. M. van Pampus
    Elisabeth C. M. van Pampus
  • MKMaria M. W. Koopman
    Maria M. W. Koopman
  • KHKarly Hamulyák
    Karly Hamulyák
  • MPMartin H. Prins
    Martin H. Prins
  • JMJan van der Meer
    Jan van der Meer
  • HBHarry R. Büller
    Harry R. Büller

Abstract
Since its identification as a risk factor for venous thromboembolism (VTE) in 1996, there is growing interest in the prothrombin 20210A mutation and its role in cardiovascular and pregnancy-related diseases.1 However, there are some unresolved issues.

This publication has 2 references indexed in Scilit: